 |
市场调查报告书
商品编码
1424485
全球生物影像市场：依影像方式、最终用户、地区划分Global Bio-imaging Market, By Imaging Modality (Magnetic Resonance Imaging, Computed Tomography, Position Emission Tomography, Ultrasound, X-ray, Others), By End User, By Geography |
||||||
全球生物成像市场规模预计将从 2023 年的 57.4 亿美元增至 2030 年的 155.8 亿美元，预测期内复合年增长率为 15.3%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2022年 | 2023/2024年市场规模 | 57.4亿美元 |
| 实际资料 | 2017-2021 | 预测期 | 2023-2030 |
| 2023/2024-2030/2031预测期复合年增长率 | 15.30% | 2030/2031价值预测 | 155.8亿美元 |
生物成像是广泛应用于生物学和医学领域的强大而重要的技术。它是指获取、处理和可视化生物系统从分子层次到器官层次的结构和功能资讯的技术集合。生物影像的主要目标是更深入地了解复杂的生物过程，促进准确的医学诊断，并指南介入和治疗。透过利用 X 射线、磁振造影(MRI)、正子断层扫描 (PET)、超音波和光学显微镜等多种技术，生物成像为了解生物体的内部结构提供了一个非侵入性的窗口。它使研究人员和临床医生能够即时观察细胞和组织内复杂的相互作用，使其成为现代诊断和疾病机制研究的基石。最近的进展已将生物成像的前沿扩展到奈米尺度，使得即时追踪细胞和分子事件成为可能。超高解析度显微镜、光声成像和生物发光等技术正在揭示前所未有的细节，加深我们对涉及健康和疾病的生物途径的理解。生物成像从根本上来说是跨学科的，涵盖物理学、工程学、生物学、化学、电脑科学和医学。它需要整合高解析度成像设备、复杂的影像分析软体以及对潜在生物过程的深入了解。作为一种应用，生物成像在实验室和医疗环境中至关重要。它有助于早期发现疾病，提高外科手术的精确度，并有助于开发标靶药物治疗。随着生物成像成像技术的不断发展，它有望透过考虑每个患者的生物组成的客製化治疗方法来彻底改变个人化医疗。因此，生物成像处于科学进步的最前沿，弥合了基础研究和临床应用之间的差距，并推动了医学创新的未来。
市场动态：
由于老年人口增加、慢性病和文明病盛行率增加、诊断成像方式的技术进步以及医疗保健支出增加等多种因素，预计全球生物成像市场在预测期内将出现强劲增长。然而，与生物成像系统、程序和放射示踪剂相关的高成本仍然是一个重大挑战。此外，一些有关辐射暴露的指导方针和法规也抑制因素了市场。儘管如此，新兴国家开拓的商机可能在不久的将来为市场相关人员开闢新的途径。
本研究的主要特点
- 本报告对全球生物成像市场进行了详细分析，并给出了以2023年为基准年的预测期（2023-2030年）的市场规模和年复合成长率（CAGR%）。
- 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
- 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
- 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球生物成像市场的主要企业。
- 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
- 全球生物成像市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进入者和财务分析师。
- 透过用于分析全球生物成像市场的各种策略矩阵，将促进相关人员的决策。
目录
第一章 研究目的与前提
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规及趋势分析
- 市场动态
- 促进因素
- 生物成像模式的技术进步
- 抑制因素
- 需要大量资金投入
- 机会
- 混合成像系统
- 监管场景
- PEST分析
- 波特的分析
- 合併、收购和合作
第四章全球生物影像市场 -冠状病毒(COVID-19) 大流行的影响
- 新型冠状病毒感染疾病（COVID-19）的流行病学
- 供需面分析
- 经济影响
第五章 全球生物影像市场（依影像方式），2018-2030 年
- 介绍
- 磁振造影(MRI)
- 电脑断层扫描 (CT)
- 位置发射断层扫描 (PET)
- 超音波
- X射线
- 其他的
第六章 全球生物影像市场，依最终使用者划分，2018-2030 年
- 介绍
- 医院和诊断中心
- 学术研究所
- 製药和生物技术公司
- 其他的
第七章 全球生物影像市场（按地区），2018-2030
- 介绍
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 欧洲其他地区
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- 东南亚国协
- 其他亚太地区
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 南非
- 中部非洲
- 北非
第八章 竞争形势
- 公司简介
- Bracco Imaging SPA
- Bayer HealthCare Pharmaceuticals
- Esaote SpA
- Digirad Corporation
- FONAR Corporation
- GE Healthcare
- Hologic Inc
- Hitachi Medical Corporation
- Lantheus Medical Imaging, Inc.
- Covidien Pharmaceuticals
- Mindray Medical International Limited.
- Gamma Medica Inc
- Samsung Medison Co., Ltd.
- Philips Healthcare
第9章 章节
- 参考
- 调查方法
- 关于出版商
Global bio-imaging market size is expected to reach US$ 15.58 Bn by 2030, from US$ 5.74 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 15.3% during the forecast period.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023/2024: | US$ 5.74 Bn |
| Historical Data for: | 2017 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023/2024 to 2030/2031 CAGR: | 15.30% | 2030/2031 Value Projection: | US$ 15.58 Bn |
Bio-imaging is a powerful and essential technique that is widely used in the realm of biological and medical sciences. It refers to the ensemble of technologies that capture, process, and visualize structural and functional information of biological systems, ranging from the molecular to the organ level. The primary goal of bio-imaging is to gain a deeper understanding of complex biological processes, facilitate accurate medical diagnoses, and guide interventions and therapies. By leveraging diverse technologies such as X-ray, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, and optical microscopy, bio-imaging provides a non-invasive window into the inner workings of living organisms. It allows researchers and clinicians to observe the intricate interactions within cells and tissues in real-time, thereby making it a cornerstone in modern diagnostics and research on disease mechanisms. Recent advancements have expanded the frontiers of bio-imaging to nano-scale dimensions and have enabled real-time tracking of cellular and molecular events. Techniques such as super-resolution microscopy, photo acoustic imaging, and bioluminescence have brought unprecedented details to light, deepening our comprehension of biological pathways involved in health and disease. Fundamentally interdisciplinary, bio-imaging encompasses physics, engineering, biology, chemistry, computer science, and medicine. It demands the integration of high-resolution imaging instruments, sophisticated software for image analysis, and a profound knowledge of the underlying biological processes. In terms of its applications, bio-imaging is indispensable in research laboratories and healthcare settings. It aids in the early detection of diseases, enhances the precision of surgical procedures, and contributes to the development of targeted drug therapies. As bio-imaging technology continues to evolve, it promises to revolutionize personalized medicine by enabling a tailored approach to treatment that considers the unique biological makeup of each patient. Thus, bio-imaging stands at the forefront of scientific progress, bridging the gap between basic research and clinical application, and driving the future of healthcare innovations.
Market Dynamics:
Global bio-imaging market is expected to witness robust growth over the forecast period, due to several factors such as rising geriatric population, increasing incidence of chronic and lifestyle diseases, technological advancements in imaging modalities, and growing healthcare expenditure. However, high costs that are associated with bio-imaging systems, procedures, and radiotracers remain a major challenge. Several guidelines and regulations pertaining to radiation exposure also act as a restraint for the market. Nevertheless, untapped opportunities in emerging economies are likely to create new avenues for market players in the near future.
Key features of the study:
- This report provides an in-depth analysis of the global bio-imaging market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global bio-imaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Esaote S.p.A, Digirad Corporation, FONAR Corporation, GE Healthcare, Hologic Inc, Hitachi Medical Corporation, Lantheus Medical Imaging, Inc., Covidien Pharmaceuticals, Mindray Medical International Limited., Gamma Medica Inc, Samsung Medison Co., Ltd., and Philips Healthcare.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global bio-imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analysing the global bio-imaging market
Detailed Segmentation:
- Global Bio-imaging Market Segmentation, By Imaging Modality:
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Position Emission Tomography (PET)
- Ultrasound
- X-ray
- Others
- Global Bio-imaging Market Segmentation, By End User:
- Hospitals & diagnostic centers
- Academic & research institutes
- Pharmaceutical & biotech companies
- Others
- Global Bio-imaging Market Segmentation, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Top Companies in Global Bio-imaging Market:
- Bracco Imaging S.P.A
- Bayer HealthCare Pharmaceuticals
- Esaote S.p.A
- Digirad Corporation
- FONAR Corporation
- GE Healthcare
- Hologic Inc
- Hitachi Medical Corporation
- Lantheus Medical Imaging, Inc.
- Covidien Pharmaceuticals
- Mindray Medical International Limited.
- Gamma Medica Inc
- Samsung Medison Co., Ltd.
- Philips Healthcare
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Bio-imaging, By Imaging Modality
- Market Bio-imaging, By End User
- Market Bio-imaging, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Technological advancements in bio-imaging modalities
- Restraints
- High capital investment requirements
- Opportunities
- Hybrid imaging systems
- Key Highlights
- Regulatory Scenario
- Recent Trends
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Global Bio-imaging Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Bio-imaging Market, By Imaging Modality, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Magnetic Resonance Imaging (MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Computed Tomography (CT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Position Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Ultrasound
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- X-ray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
6. Global Bio-imaging Market, By End User, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Hospitals & diagnostic centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Academic & research institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Pharmaceutical & biotech companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
7. Global Bio-imaging Market, By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 -2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Company Profile
- Bracco Imaging S.P.A
- Company Highlights
- Imaging Modality Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer HealthCare Pharmaceuticals
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Esaote S.p.A
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Digirad Corporation
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- FONAR Corporation
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hologic Inc
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hitachi Medical Corporation
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lantheus Medical Imaging, Inc.
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Covidien Pharmaceuticals
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mindray Medical International Limited.
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Gamma Medica Inc
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Samsung Medison Co., Ltd.
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Philips Healthcare
- Company Highlights
- Imaging Modality Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- References
- Research Methodology
- About us
